News & Press Releases

  • Cardiovascular Translational Research Webinar

    Watch Our First Webinar of 2022! ViVitro Labs and The Cardiovascular Translational Lab at St. Paul’s Vancouver Canada bring the latest in translational cardiovascular research in a quarterly interactive webinar format. The January 17th webinar,  Hemodynamics after TAVR! featuring Dee Dee Wang MD and Amr Abbas MD, is now available for viewing. The Discussion Panel with moderators […]

  • How Feasibility Studies Solve Three Frequently Asked Testing Questions

    Three frequently asked questions from lab clients are: How many samples do I need? What acceptance criteria should I use? Can I submit first results to a regulatory body? “Run a feasibility study first” is usually the best answer to all these questions. This ViVitro Labs Tech Brief explains how and why a feasibility study […]

  • In-line Continuous Particulate Counting for Acute Particulate Evaluation 

    Are you developing or does your device interact with guidewires, guiding catheters, introducer sheaths, stents, or stent-grafts? Acute Particulate Evaluation can speed development of your devices. Medical device systems used during interventional procedures can unintentionally release particles during use. Depending on the treatment location, and the patient history, particles introduced into the bloodstream during a […]

  • Changes to ISO 5840:2021 Standards

    By Robert Fraser ISO 5840-1, 5840-2, and 5840-3 were published on January 22, 2021. This document highlights changes from previous versions of the standard on select in-vitro testing requirements. Additional major changes, including updates to the pre-clinical and clinical section, are not covered here. A good  summary of the ISO 5840 standards can be found […]

Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.